Pharmaceutical companies are increasingly under pressure to reduce the time it takes to discover new medicines. Recent advances in biophysical screening technology have made the detection of binding events associated with the smallest of fragments possible.
Often the biological target of interest has been determined but the identification of a suitable chemical starting point to optimize and deliver a drug candidate can often slow down the discovery process.
Watch this webinar to learn more about:
Technology Networks Limited
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK
Email: privacy@technologynetworks.com
© 2020 Technology Networks. All rights reserved
Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy